Pricing Log in Create free account

Aura Biosciences, Inc. (AURA) vs Design Therapeutics, Inc. (DSGN)

Aura Biosciences, Inc. and Design Therapeutics, Inc. are both Biotechnology companies. Aura Biosciences, Inc. and Design Therapeutics, Inc. are of similar size ($657.5M and $655.9M). Across the 8 metrics below, Design Therapeutics, Inc. leads on 5 and Aura Biosciences, Inc. on 3.

Valuation

Metric AURA DSGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 2,851.44 9.71
P/B 1.84 3.19 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1,933.76 9.21
Earnings yield (28.69%) (11.45%) (33.15%)
Free cash flow yield (17.86%) (8.57%) (25.50%)

Profitability

Metric AURA DSGN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (53.49%) (34.13%) (56.36%)
Return on assets (47.42%) (32.33%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AURA DSGN Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (0.57%) (38.64%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AURA DSGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 16.82 18.86 4.72
Net debt to EBITDA 1.29 2.68 0.96

Dividend

Metric AURA DSGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AURA DSGN Biotechnology median
Market cap 657.49m 655.86m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack